The microtubule network exerts multifarious functions controlled by its decoration with various proteins and post-translational modifications. The disordered microtubule associated Tubulin Polymerization Promoting Protein (TPPP/p25) and the NAD + -dependent tubulin deacetylase sirtuin-2 (SIRT2) play key roles in oligodendrocyte differentiation by acting as dominant factors in the organization of myelin proteome. Herein, we show that SIRT2 impedes the TPPP/p25promoted microtubule assembly independently of NAD + ; however, the TPPP/p25-assembled tubulin ultrastructures were resistant against SIRT2 activity. TPPP/p25 counteracts the SIRT2-derived tubulin deacetylation producing enhanced microtubule acetylation. The inhibition of the SIRT2 deacetylase activity by TPPP/p25 is evolved by the assembly of these tubulin binding proteins into a ternary complex, the concentration-dependent formation of which was quantified by experimental-based mathematical modelling. Co-localization of the SIRT2-TPPP/p25 complex on the microtubule network was visualized in HeLa cells by immunofluorescence microscopy using Bimolecular Fluorescence Complementation. We also revealed that a new potent SIRT2 inhibitor (MZ242) and its proteolysis targeting chimera (SH1) acting together with TPPP/p25 provoke microtubule hyperacetylation, which is coupled with process elongation only in the case of the degrader SH1. Both the structural and the functional effects manifesting themselves by this deacetylase proteome could lead to the fine-tuning of the regulation of microtubule dynamics and stability.
Results
Assembly of SIRT2 with TPPP/p25 and/or tubulin. The interaction of SIRT2 with TPPP/p25 as well as their associations to tubulin was characterized by circular dichroism (CD) and enzyme-linked immunosorbent assay (ELISA). As illustrated in Fig. 1a , the spectrum of the human recombinant SIRT2, similarly to that of tubulin, shows characteristic features typical for α-helical proteins with two prominent minima at 208 and 222 nm 40 ; while the spectrum of TPPP/p25 corresponding to that of disordered proteins displays a minimum at 205 nm 7 . The pair-wise association of TPPP/p25 and SIRT2 generated a difference ellipticity spectrum with a maximum at nearly 207 nm indicating secondary structural changes likely in the disordered TPPP/p25 ( Fig. 1b) , similarly as reported for the complex of TPPP/p25 with tubulin 7 .
The pair-wise interactions were quantified by ELISA ( Fig. 2a ): SIRT2 was immobilized on the plate, then TPPP/p25 or tubulin was added at various concentrations and their binding to SIRT2 was detected by specific TPPP/p25 or tubulin antibodies as described in the Materials and Methods. The apparent dissociation constant was K d = 32.4 ± 4.6 nM for the association of TPPP/p25 and SIRT2, while it was significantly higher for SIRT2-tubulin (K d ≥ 2 μM). These results, according to the earlier data 29 , indicate the preferential association of SIRT2 to TPPP/p25 as compared to tubulin.
These data were used to reveal the nature of the association of SIRT2 with tubulin in the presence of TPPP/p25. In the competitive ELISA experiments, SIRT2 was immobilized on the plate, then tubulin was added at various concentrations preincubated without or with TPPP/p25 of constant concentration. The SIRT2-bound TPPP/p25, as quantified by the immunopositivity, decreased by the increase of tubulin concentration suggesting a reduced SCIENtIfIC RePORTs | 7: 17070 | DOI:10.1038/s41598-017-17381-3 binding potency of tubulin-bound TPPP/p25 to the immobilized SIRT2 ( Fig. 2b) . In another ELISA experiment, 1 μM tubulin or 0.25 μM TPPP/p25 or their preincubated mixture was added to the immobilized SIRT2, then both the bound tubulin and TPPP/p25 were detected by specific antibodies. Surprisingly, the comparison of these data with those obtained with binary complexes revealed that the presence of TPPP/p25 increased the amount of the bound tubulin, while the addition of tubulin reduced the binding of TPPP/p25 to SIRT2 (Fig. 2c ). These findings show that i) both TPPP/p25 and SIRT2 are associated to tubulin; ii) the ratio of the binary and ternary complexes of SIRT2 depends on the concentration of the partners; iii) an excess tubulin level could produce an apparent competitive binding.
An experiment-based mathematical model was established to study the nature of the heteroassociations in relation to the formation of binary and ternary complexes depending on the tubulin concentration. Two types of models were evaluated: a competitive model assuming exclusively binary complexes, and a ternary complex model allowing the formation of the TPPP/p25-SIRT2-tubulin complex. The models include the dissociation constants of the binary complexes of tubulin, SIRT2 and TPPP/p25 determined experimentally as well as the total concentrations of the individual proteins (for details see Supplementary data and Supplementary Table S1 ). Figure 3 shows the binding of tubulin to the immobilized SIRT2 in the absence and presence of TPPP/p25 (cf. Fig. 2c ) as well as the theoretical curves. The comparison of the computed and the experimental data of the ELISA experiments referring to the concentration-dependent binding of tubulin to SIRT2 in the presence of TPPP/p25 underlines the necessity of ternary complex formation to obtain appropriate fitting. The quantitative data determining the nature of the complexes render the evaluation of the ratio of the binary/ternary complexes possible.
SIRT2 reduces the TPPP/p25-promoted tubulin assembly in vitro.
After revealing the interactions of SIRT2 with TPPP/p25 and/or tubulin, the functional consequences of the heterologous associations were characterized: on one hand, the role of SIRT2 in the TPPP/p25-promoted tubulin assembly; on the other hand, the role of TPPP/p25 in the SIRT2-derived tubulin deacetylation. The following types of experiments were performed as illustrated in Fig. 4 : i) TPPP/p25-induced tubulin polymerization as detected by turbidimetry; ii) determination of the partition of proteins in the supernatant and pellet fractions of the samples obtained in the tubulin polymerization assay; iii) quantification of the tubulin acetylation degree by Western blot; iv) visualization of the assembled tubulin structures by electron microscopy.
Previously, we reported that TPPP/p25 promotes tubulin polymerization in vitro resulting in intact-like and bundled MTs as well as amorphous aggregates 7 . At cellular level, the ultrastructure of the MT network is highly dependent on the expression level of TPPP/p25: in transiently transfected HeLa cells at low expression level TPPP/p25 is aligned along the MT network without significant morphological alterations; at high expression level both perinuclear cage and aggresome structures are formed 41 .
As shown in Fig. 4 , SIRT2 decreases the tubulin polymerization activity of TPPP/p25, when they were premixed, as indicated by the reduced turbidity level; the effect appears to be independent of the presence of NAD + (Fig. 4a ). When the same set of experiments was performed, however, SIRT2 was added to the TPPP/ p25-assembled tubulin (control curve at 6 min in Fig. 4a ), there was no significant decrease in the turbidity ( Supplementary Table S2 ). This finding indicates the resistance of the TPPP/p25-assembled MT ultrastructures against the destructive effect of SIRT2. The ultrastructures formed by the TPPP/p25-promoted tubulin polymerization were visualized by electron microscopy in the presence of either active or inactive SIRT2 (Fig. 4b ). The results of this set of experiments unambiguously show that SIRT2, when it was premixed with TPPP/p25, counteracts the TPPP/p25-induced tubulin polymerization independently of its catalytic activity.
The samples were pelleted and analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS/ PAGE) to visualize the partition of soluble and assembled tubulins complexed with TPPP/p25 and/or SIRT2; in addition, Western blot analysis using acetyl-tubulin antibody was carried out to detect the acetylation levels of the MT ultrastructures formed by the addition of TPPP/p25 premixed with SIRT2 or by addition of SIRT2 to the TPPP/p25-assembled MT. The SDS/PAGE data show that the partition of the proteins in the supernatant and pellet fractions was independent of the presence of NAD + , and SIRT2 did not affect significantly the partition of tubulin and TPPP/p25 when it was added to the TPPP/p25-assembled MT ( Supplementary Figs S2 and S3 ). However, the acetylation level was significantly higher in the case of the TPPP/p25-promoted MT ultrastructures ( Fig. 4d , Supplementary Fig. S2 ) as compared to those formed by the addition of TPPP/p25 premixed with SIRT2 ( Fig. 4c , Supplementary Fig. S2 ). The acetylation level of the TPPP/p25-promoted MT ultrastructures was similar to that of the control sample (no SIRT2), these ultrastructures displayed resistance against the deacetylase activity of SIRT2. This finding suggests that certain acetylated sites of the assembled tubulin are not accessible for SIRT2. and tubulin (○), when the plate was coated with SIRT2; and that of tubulin (▲), when the plate was coated with TPPP/p25. Concentrations of the coated proteins were 5 μg/ml. The data are presented as mean ± SD, n = 3 for TPPP/p25-SIRT2, n = 4 for tubulin-SIRT2, and n = 11 for TPPP/p25-tubulin. (b) Displacement of 125 nM TPPP/p25 from the coated SIRT2 by tubulin added at various concentrations detected by TPPP/p25 antibody. The data are presented as mean ± SD, n = 3. (c) Binding of TPPP/p25 (250 nM) and tubulin (1 μM) to the immobilized SIRT2 as detected by TPPP/p25 and tubulin antibodies, respectively. The data are presented as mean ± SD, n = 4. *p = 2.61E-04 when TPPP/p25 with tubulin compared to TPPP/ p25 alone, and *p = 1.76E-02 when tubulin with TPPP/p25 compared to tubulin alone (two-sided, unpaired Student's t-test).
SCIENtIfIC RePORTs | 7: 17070 | DOI:10.1038/s41598-017-17381-3 TPPP/p25 inhibits the SIRT2-mediated tubulin deacetylation. To study the effect of TPPP/p25 on the SIRT2-derived tubulin deacetylation, the deacetylase activity of SIRT2 was measured on acetyl-tubulin, and quantified by Western blot using specific acetyl-tubulin antibody. Figure 5 and Supplementary Fig. S4 show that SIRT2 decreased the acetylation level of tubulin in a concentration-dependent manner. At a given SIRT2 concentration (1.5 µM), increasing TPPP/p25 concentrations provoked an increase in the tubulin acetylation level suggesting a reduced deacetylation activity of SIRT2 due to its interaction with TPPP/p25. This finding is consistent with the binding (cf. Fig. 2 ) and the modelling data (cf. Fig. 3 ), namely, that SIRT2 is involved in the formation of both binary and ternary complexes which display distinct deacetylase activity; in fact, modest inhibitory effect of TPPP/p25 on the SIRT2-mediated tubulin acetylation level can be concluded.
Mutual effect of TPPP/p25 and chemical inhibitors on the SIRT2-derived deacetylation of tubulin.
To examine whether the small molecule SIRT2 inhibition is affected by the presence of TPPP/p25 as an interacting partner as well as a deacetylase inhibitor, we used a novel class of SIRT2 inhibitors, the SirReals, displaying high inhibitory potency with unique mechanism 36 . In addition, a SirReal-derived PROTAC was used as well, which selectively initiates the proteasomal degradation of SIRT2 39 . Nicotinamide, a well-established inhibitor of SIRT2, was also used as a control 42 . We quantified the effects of the SirReals alone or in combination with TPPP/ p25 by Western blot using the endogenous SIRT2 substrate, tubulin, as described in the Materials and Methods. As shown in Fig. 6a (and Supplementary Fig. S5 ), the efficacy of the different drug-like compounds against the deacetylase activity of SIRT2 is comparable with that of TPPP/p25.
The effect of drug-like inhibitors on the association of SIRT2 to TPPP/p25 was tested by ELISA. Figure 6b shows that the compounds MZ242, MZ25 and SH1 (PROTAC) do not influence the interaction of SIRT2 and TPPP/p25 significantly up to 30 μM, indicating that the interface segment of the heterocomplex is different from the binding site of the chemical inhibitor. Then we evaluated the functional effects of the mutual SIRT2 inhibition by TPPP/p25 and the drug-like inhibitors on the tubulin acetylation level by Western blot using acetyl-tubulin antibody ( Fig. 6c , Supplementary Fig. S6 ). Indeed, a combination of the potential anticancer agents and TPPP/ p25 is superior as compared to their individual effects. It should be noted that under in vitro conditions in absence of the proteasomal machinery the PROTAC can only function by inhibiting the deacetylase activity of SIRT2 and not as a degrader.
Localization of the complex of TPPP/p25 and SIRT2 on the microtubule network in HeLa cells.
Previously we revealed the co-localization of TPPP/p25 with the MT network in transiently transfected HeLa cells resulting in distinct MT ultrastructures 41 . The cancerous HeLa cells express TPPP/p25 endogenously at a very low level; the MT network is virtually deacetylated, however, ectopic expression of TPPP/p25 induces acetylation of the MT network 16 . In order to validate the in vitro data obtained with isolated proteins, we performed experiments with HeLa cells using bimolecular fluorescence complementation (BiFC) technology: mVenus vectors of both SIRT2 and TPPP/p25 (V N -SIRT2 and V C -TPPP/p25) (cf. Fig. 7a ) were prepared as described in the Materials and Methods.
As shown in Fig. 7a , the N-terminal and the C-terminal domains of a fluorescent protein (Venus) are fused separately to two partner proteins, SIRT2 and TPPP/p25. The intracellular heteroassociation of the labelled proteins, V N -SIRT2 and V C -TPPP/p25, brings the two domains of the split fluorescent Venus protein in close proximity, which results in a fluoresce emission upon excitation, a BiFC signal. The control experiment shows that the empty Venus vector does not produce a BiFC signal 43 (see Supplementary Fig. S7 ). Figure 7b shows that the application of BiFC technique coupled with immunofluorescence microscopy enabled not only the visualization of the BiFC complex of SIRT2 and TPPP/p25 (green), but also its localization on the MT network. To further probe the specificity of the interaction of the TPPP/p25-SIRT2 complex and the BiFC signal, the cells were co-transfected with unlabelled TPPP/p25 or α-synuclein. As expected, co-transfection with either unlabelled TPPP/p25 or α-synuclein (interacting partner of TPPP/p25 9, 22 ) resulted in a significant decrease of the BiFC signal corresponding to the disruption of the Venus complex ( Fig. 7c, Supplementary Fig. S7 ). The established cellular model was also used to validate the effect of the SIRT2 inhibitor, MZ25, on the assembly of SIRT2 and TPPP/p25. In accordance with the in vitro data, the addition of MZ25 did not influence the interaction of SIRT2 with TPPP/p25, the BiFC signal intensity was unchanged ( Fig. 7c, Supplementary Fig. S7 ).
Finally, we have probed the mutual effects of TPPP/p25 and small molecule derived SIRT2 inhibition/degradation (MZ242/SH1), on the acetylation level of the MT network in living cells by immunofluorescence microscopy using acetyl-tubulin antibody ( Fig. 8, Supplementary Fig. S8 ). While the small molecule derived inhibitors/ degraders are taken up by all cells from the medium ( Supplementary Fig. S8 ), TPPP/p25 is only expressed in the transiently transfected HeLa cells as identified by immunostaining (green) ( Fig. 8a and c) . Since the combined acetylation is visible only in the TPPP/p25 expressing cells (few in the images), the immunopositivity for acetyl-tubulin was determined in the transfected cells in the absence and presence of chemical inhibitors on the basis of the fluorescent signal produced by the acetyl-tubulin antibody (red) as described in the Materials and Methods (Fig. 8b and d) . According to the quantified data, the tubulin acetylation level is increased with approximately 40% by chemical compounds as compared to the cells transfected with TPPP/p25. Therefore, a competitive effect of TPPP/p25 and small molecule derived degrader SH1 or the inhibitor MZ242 can be ruled out; on the contrary, further hyperacetylation of the MT network due to the combination of TPPP/p25 and chemical inhibitors can be concluded in agreement with the in vitro data (cf. Fig. 6c ). Recently, it has been revealed that the PROTAC derivative SH1 as a SIRT2 degrader induces process elongation in HeLa cells in addition to the hyperacetylation of the MT network 39 . Now we have revealed that i) this effect is specific for the SH1 degrader since no such effect can be visualized in the case of MZ242 inhibitor (Fig. 8a and c) ; ii) the SH1 PROTAC effect is maintained in the presence of TPPP/p25; iii) similar morphological alteration has been visualized in the case of tubulin staining using tubulin antibody as for acetyl-tubulin ( Fig. 8c, Supplementary Figs S8 and S9) indicating that the MT network is completely reorganized. was added to the acetyl-tubulin. The data are presented as mean ± SD, n = 3-11. *p = 5.56E-06 for TPPP/p25, *p = 1.53E-03 for SH1, *p = 1.38E-03 for MZ242 and *p = 1.60E-03 for 1 mM nicotinamide when the values with and without inhibitor were compared in the case of tubulin as a substrate (two-sided, unpaired Student's t-test). Images of the full-length blots/gels are presented in Supplementary Fig. S5. (b) Effect of the inhibitors on the binding of 125 nM TPPP/p25 to the immobilized SIRT2 detected by ELISA as described in the Materials and Methods. The data are presented as mean ± SD, n = 3. (c) Mutual effect of the TPPP/p25 and the chemical inhibitors on the SIRT2 activity (Western blot data with tubulin). The data are presented as mean ± SD. n = 4 for tubulin, tubulin with SIRT2, tubulin with SIRT2 and 10 μM TPPP/p25, tubulin with SIRT2 and 5 μM MZ242, and tubulin with SIRT2 and 10 μM TPPP/p25 and 5 μM MZ242; n = 3 for tubulin with SIRT2 and 5 μM SH1, and tubulin with SIRT2 and 10 μM TPPP/p25 and 5 μM SH1. *p = 1.06E-05 for TPPP/p25, *p = 4.96E-03 for MZ242 and *p = 1.38E-03 for SH1 when the values with and without inhibitor were compared (two-sided, unpaired Student's t-test). Images of the full-length blots/gels are presented in Supplementary Fig. S6 .
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Discussion
Deacetylation of α-tubulin at Lys-40 residue is catalysed by two atypical histone deacetylases, the NAD + -dependent SIRT2 25 and the Zn 2+ -dependent HDAC6 24 , which are potential anti-cancer drug targets 3 ; their inhibition provokes the hyperacetylation of the MT network 3 . MAPs such as tau, MAP2c or MAP1B have been suggested to bundle MTs enriched in acetylated α-tubulin leading to resistance against MT depolymerizing agents 44 . Furthermore, the acetylated tubulin residues in these MT bundles are also not accessible to SIRT2 28, 44 . TPPP/p25, a recently defined MAP, also induces MT bundling and increases the tubulin acetylation; however, the resistance of the MT network against anti-mitotic agents is caused by the TPPP/p25-mediated cross-linking of the MTs and not by its enhanced acetylation 16 .
Previously we reported that TPPP/p25 interacts with both HDAC6 16 and SIRT2 29 ; however, the functional consequences of the interaction of TPPP/p25 with SIRT2 have not been elucidated. Here we have shown that SIRT2 reduces the TPPP/p25-induced tubulin assembly in vitro, it counteracts the tubulin polymerization promoting/MT bundling potency of TPPP/p25 independently of its deacetylase activity (cf. Fig. 4) ; however, this effect does not occur when SIRT2 is added to the TPPP/p25-assembled tubulin (no turbidity change) (cf. Fig. 4 and Supplementary Figs S2 and S3 ). Furthermore, the TPPP/p25-promoted ultrastructures, which show resistance against deacetylation, are not accessible for SIRT2 (cf. Fig. 4 and Supplementary Figs S2 and S3 ).
The assembly of the three partner proteins, tubulin, TPPP/p25 and SIRT2 has been demonstrated i) at molecular level: the binding of tubulin to SIRT2 is stimulated by the presence of TPPP/p25 as detected by ELISA (cf. Fig. 2) ; ii) at cellular level: the co-localization of the TPPP/p25-SIRT2 complex on the MT network is established by immunofluorescence microscopy coupled with BiFC; iii) by experiment-based mathematical modelling (ternary complex model) (cf. Fig. 3 ). The knowledge of the specific activity of SIRT2 within the binary and ternary complexes allows one to predict the acetylation level at different concentrations of the proteome components at different conditions. It has been reported that SIRT2 alone does not bind to tubulin 25, 45 . This is in agreement with our in vivo data ( Supplementary Fig. S10 ). In fact, we were not able to detect intracellular co-localization of SIRT2 with the MT network in HeLa cells. A significant feature of the tubulin acetylation-promoting system has been identified, TPPP/p25, as an interacting partner of both tubulin and SIRT2, can effectively promote the binding of SIRT2 to tubulin likely in a piggy-back manner ensuring a fine-tuning mechanism for the regulation of the acetylation level of the MT network. This control could be mediated via conformation changes within the ternary complex leading to the attenuation of SIRT2 deacetylase potency.
Both TPPP/p25 [18] [19] [20] and SIRT2 3, 31, 33, 34, 46 are endogenously expressed in the differentiated OLGs, the major constituents of the myelin sheath. The knockdown of TPPP/p25 by siRNA or microRNA impeded the differentiation of OLGs 19 . The knockdown of SIRT2 by siRNA was reported to increase tubulin acetylation and the complexity of cellular arborisation 46 , as well as to block differentiation of OLGs (CG-4 cells) 47 , while its over-expression facilitated cell process growth 47 . However, the abundance of endogenous SIRT2 expression in cultured primary OLG precursors positively correlated with elevated tubulin acetylation and differentiation suggesting its counterbalancing role to prevent uncontrolled acetylation 46 . The detailed mechanism of these complex processes is largely unknown, nevertheless, the regulation of MT stability and dynamics through the interplay of SIRT2 and TPPP/p25 may represent an important mechanism in the cytoskeletal control either during oligodendrogenesis or in mature OLGs. Other MAPs also have been proposed to interact with SIRT2 in a highly specific manner, for example, the protein Furry plays a crucial role in promoting MT acetylation level in the mitotic spindle by inhibiting SIRT2 as demonstrated in HeLa cells 48 . (c) Cells treated with SH1. Note that the chemical compounds are taken up from the medium, while TPPP/p25 is expressed only in some of the cells. Nuclei are counterstained with DAPI (blue). Scale bar: 5 μm. The acetyltubulin signal (red) was quantified in the transfected and non-transfected cells as described in the Materials and Methods. The data are presented as mean ± SD, at least 25 cells (in the case of MZ242, b) or 50 cells (in the case of SH1, d) were analysed. *p = 9.20E-3 and *p = 3.34E-5 when TPPP/p25 transfected cells were compared with those treated with MZ242 and SH1 as well, respectively (two-sided, unpaired Student's t-test).
The control of the acetylation level of the MT network is an important factor for the regulation of MT architecture and maintenance of its integrity 3 , in fact, the non-physiological deacetylation including hyperacetylation has been proposed to play a role in the aetiology of distinct human diseases 3, 49, 50 . Consequently, the destruction of the cytoskeletal MT system or its over-stabilization leads to cell death. A number of anti-MT drugs have been reported that display such features 51 . The basic problem in cancer therapy is to target specifically the tumour cells, to destroy only their cytoskeletal MT network. Recently, a highly potent and SIRT2 selective inhibitor class, the SirReals, has been discovered, which provokes hyperacetylation of the MT network 36 . Based on these inhibitors, a PROTAC was developed that was shown to induce the proteasomal degradation of SIRT2 chemically 39 . In contrast to the SirReals, the SirReal-derived PROTAC does not only affect the acetylation level of the MT network, but results in process elongation as well. The novel achievements presented in this paper in relation to the control of the MT acetylation level could contribute to our understanding of the multifarious functions of the MT system as well as may provide a clue for innovative strategy in cancer research.
Materials and Methods
Inhibitors. The inhibitors were synthesized according to established procedures: MZ25 (SirReal2) 36 and MZ242 (cpd 10) 38 are inhibitors of the enzymatic activity of SIRT2. SH1 is a PROTAC, linking a partial structure of MZ242 and thalidomide via a spacer 39 (Supplementary Fig. S1 ). Nicotinamide was included in the SIRT2 assay kit (BPS Bioscience, 50087).
BiFC plasmids. The BiFC plasmids (pBiFC-VN1-173, pBiFC-VC155-238) were a gift of Prof. Péter Várnai (Semmelweis University, Budapest). The V C -TPPP/p25 plasmid containing the insert for human full length TPPP/p25 was prepared as described previously 14, 43 . Plasmid V N -SIRT2 was produced by inserting the SIRT2 coding region in frame 25 into pBiFC-VN1-173 by XhoI and BamHI restriction enzymes. The sequences of all construct were verified by restriction mapping and sequencing.
Cloning of SIRT2.
Human recombinant hexaHis-tagged SIRT2 containing residues 50-356 was cloned and expressed in Escherichia coli (E. coli) BL21 (DE3) cells. The constructs of 50-356 SIRT2 were amplified with 5′ primer containing a NdeI site with sequence: 5′-GCACCATATGGACAGCCTGGGCAGCCAGAAGG -3′ and 3′ primer containing a XhoI site with sequence 5′-GCAATCTCGAGCGACTGGGCATCTATGC -3′. The resulting PCR fragments were inserted into the NdeI and XhoI sites of the pET21c vector and were confirmed by sequencing.
Expression and purification of human recombinant wild type TPPP/p25 and SIRT2. The C-terminal hexaHis fusion proteins were expressed in E. coli BL21 (DE3). TPPP/p25 was isolated on HIS-Select ™ Cartridge (Sigma-Aldrich) as described previously 43 . SIRT2 was prepared as described by Sun and co-workers 52 . Briefly, the ampicillin-resistant cells were grown in LB containing 100 mg/l ampicillin, 1 mM MgCl 2 and 5 µM ZnCl 2 at 37 °C, then harvested by centrifugation (20 min, 4 °C, 2000 g). The pellet fraction was resuspended in phosphate buffer (50 mM Na 2 HPO 4 , 300 mM NaCl, pH 8.0 containing 10 μM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 1 mM benzamidine, 1 μg/ ml pepstatin and 1 μg/ml leupeptin) and lysed by sonication. Following centrifugation (25 min, 4 °C, 39,000 g), the supernatant containing the soluble proteins was affinity purified by Ni 2+ affinity gel. The bound protein was eluted by 50 mM Na 2 HPO 4 , 300 mM NaCl, pH 8.0 containing 50 mM imidazole. Then the protein was concentrated and stored in 50 mM tris(hydroxymethyl)aminomethane, 200 mM NaCl (pH 8.0), 10% glycerol and 1 mM dithioerythritol.
Concentration of TPPP/p25 and SIRT2 was determined at 280 nm by the extinction coefficients evaluated by ProtParam (http://web.expasy.org/protparam/): 10,095 M −1 *cm −1 for TPPP/p25 and 33203 M − 1 *cm − 1 for SIRT2, respectively. Tubulin preparation. Tubulin was prepared from bovine brain according to the method of Na and Timasheff 53 . It is important to note that the preparation was carried out without adding zinc cation or NAD + to the buffer compositions used for the preparation of cell extracts or to the ammonium sulphate precipitations. CD measurements. CD measurements were performed on a Jasco J-720 spectropolarimeter at 20 nm/min scan rate, 8 s time constant and 1 nm step size in 10 mM phosphate buffer, pH 7.4 at room temperature. The path length was 0.1 cm. Protein concentrations were 4 μM for TPPP/p25, 1 μM for tubulin and 16 μM for SIRT2. The difference spectrum was obtained by subtracting the spectra of the individual proteins from that of the mixture of two proteins. Mean molar ellipticity per residue (MRE) in degrees square centimetre per decimole was calculated according to the following equation: MRE = Θ m /(10*n*c*l), where Θ m is the measured ellipticity (millidegrees), n is the number of amino acid residues in a protein, c (mol) is the concentration and l (cm) is the path length of the cell. Data from three independent measurements were averaged.
ELISA.
ELISA experiments were performed as described previously 22 . Briefly, the plate was coated with
In the case of the competitive ELISA experiments, SIRT2 was immobilized on the plate, tubulin was preincubated with TPPP/p25 at different concentrations, then the binding of TPPP/p25 and that of tubulin were detected by specific TPPP/p25 and tubulin antibodies, respectively. In another set, 125 nM TPPP/p25 was preincubated with MZ25, MZ242 or SH1 at different concentrations, and the binding of TPPP/p25 to the immobilized SIRT2 was detected.
Turbidimetry and pelleting experiments. The assembly of tubulin (6 μM) was assessed in polymerization buffer (50 mM 2-(N-morpholino)ethanesulfonic acid buffer, pH 6.6, containing 100 mM KCl, 1 mM dithioerythritol, 1 mM MgCl 2 , and 1 mM ethylene glycol tetraacetic acid) at 37 °C in the presence of TPPP/p25 (3 μM) with/or without SIRT2 (25 μM) and NAD + (500 μM). The tubulin polymerization was induced by the addition of TPPP/p25 or TPPP/p25 premixed with SIRT2. When indicated, SIRT2 was added to the TPPP/p25-assembled tubulin at 6 min; after incubation for further 6 min, the absorbance of samples was measured. The optical density was monitored at 350 nm by a Cary 100 spectrophotometer (Varian, Walnut Creek, Australia).
In the pelleting experiments the polymerized samples (100 μl aliquot) were centrifuged (15 min, 37 °C, 17000 g), and the pellet (P) and the supernatant (S) fractions were separated. The pellet fractions were resuspended in 100 μl polymerization buffer. The fractions were analysed by SDS/PAGE, Western blot using acetyl-tubulin antibody (Sigma T6793), and electron microscopy. For SDS/PAGE and Western blot experiments, MM indicates the molecular weight marker (PageRuler Prestained Protein Ladder, Thermo Scientific 26616).
Electron microscopy. For electron microscopy, MT-containing samples were pelleted by centrifugation (15 min, 37 °C, 17000 g), and the pellets were fixed in a mixture of 2% glutaraldehyde, 0.2% tannic acid in 0.1 M sodium cacodylate, pH 7.4, for 1 h at room temperature and for 24 h at 4 °C, and then embedded in Durcupan (Fluka, Switzerland). Ultrathin sections were contrasted with Reynold's lead citrate and examined and photographed in a Jeol JEM-1011 electron microscope, operating at 60 kV, equipped with Olympus Morada CCD camera using Olympus iTEM (TEM imaging platform) software. SIRT2 activity assays. Tubulin. SIRT2 was incubated with 2.64 μM tubulin, 0.5 mM NAD + , 0.1 mg/ml bovine serum albumin without or with TPPP/p25 and/or drugs in assay buffer (BPS Bioscience, 50031) for 1 h at 37 °C. Nicotinamide (1 mM) was used as a positive control of SIRT2 inhibitors 42 . The samples were analysed by 13.5% SDS/PAGE, stained with Coomassie Brilliant Blue R-250 containing 2-mercaptoethanol. The same samples were also electrotransferred onto Immobilon-P SQ transfer membranes and subjected to Western blot. The blot was developed using a monoclonal mouse antibody against acetylated α-tubulin at Lys-40 (1:5000, clone 6-11B-1, Sigma T6793), antibody binding was revealed by anti-mouse IgG-peroxidase conjugate (Fc-specific), (1:5000, Sigma A2554). Peroxidase reaction was detected using Immobilon Western substrate (Millipore) by a Bio-Rad ChemiDoc MP Imaging system and its ImageLab 4.1 software. Then amido black solution (0.1% w/v amido black, 25% v/v isopropanol and 10% v/v acetic acid) was applied to stain the protein bands on the membrane for 1 min. Intensity of bands was analysed by ImageJ 1.49 using Measure command and subtracting background values. Relative acetyl-tubulin level corresponds to the difference measured in absence and the presence of 0.6 μM SIRT2.
Cell culture and manipulation. HeLa cells (ATCC ® CCL-2 ™ , American Type Culture Collection) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and 100 μg/ml kanamycin in a humidified incubator at 37 °C with 5% CO 2 . Cells were grown on 12-mm-diameter glass coverslips for microscopic analysis. For the evaluation of the Venus signal, HeLa cells were transfected with the full length Venus (Addgene) or its fragments V N 1-173 and V C 155-238 (empty Venus) or V C -TPPP/p25 and V N -SIRT2 (0.3 μg of each plasmid), in the case of competition with an additional 0.1 µg TPPP/p25 41 or α-synuclein construct (OriGene); Turbofect (Invitrogen) transfection reagent was used according to the manufacture's protocol. The cells were treated with 20 μM MZ25 for 3 hours where indicated. After treatment, the cells were fixed with −20 °C methanol for 10 min, followed by postfixation with 4% formaldehyde (Sigma) for 2 min. After washes with PBS (3 × 10 min), samples were blocked for 30 min in PBS with 0.1% Triton X-100 (Sigma) containing 5% fetal calf serum. Mouse monoclonal tubulin (Sigma T9026), rat polyclonal TPPP/p25 21 , rabbit polyclonal SIRT2 (abcam ab67299), Alexa 546 conjugated mouse, rat and rabbit secondary antibodies (Thermo Fisher Scientific A11030, A11081 and A11010) were used for the detection of the tubulin, TPPP/p25 and SIRT2 signal. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). In another experiment, HeLa cells were transfected with TPPP/p25 for 24 hours using the same protocol, then inhibitors (10 µM MZ242 or SH1) were added to the samples for the last 3 hours of the experiment. Samples were fixed and processed as above. TPPP/p25-transfected cells were detected with a polyclonal anti-TPPP/p25 serum developed in rat 21 , and labelled by anti-rat Alexa 488 (Thermo Fisher Scientific A11006). Acetyl-tubulin was detected as above. Images of the mounted samples were acquired on a Leica DM IL 500 microscope equipped with Leica DFC 395 FX camera and HBO 100w lamp. Red channel (acetyl-tubulin) or green channel (BiFC) experiments were detected with fixed exposition parameters. The equipment software was Leica Application Suite 4.4.0. Chroma UV filter set (No. C40888), Chroma 41028 HQ NB GFP filter set (No. C21116), Chroma 41028 Y GFP filter set (No. C2117) and Leica filter N2.1 (No. 513832) was used for DAPI, Alexa 488 (and EGFP), BiFC and Alexa 546 signal acquisition, respectively, using a HCX FL Fluotar 40x/0.75 (dry) objective. RGB images were created using Adobe Photoshop CS2 by copying the original greyscale microscopic images (1600 × 1200 pixels, 600 dpi, 8-bit tiff images) into the corresponding red, green, or blue channel, respectively. A minimal background correction was applied by the same way for channels of the selected subpictures. In the presented images, original pixel density was changed to 450 dpi without recalculation.
For the quantitative analysis of the images, the pictures were taken under constant exposure parameters. The determination of the BiFC signal (green, Fig. 7 , in each case at least 90 cells were analysed) and the acetyl-tubulin signal (red, Fig. 8 , in each case at least 25 cells were analysed) was performed by using the Analyse, Measure option of the National Institutes of Health ImageJ software using the original grayscale pictures without modification. The whole territory of each cell was outlined by the Freehand Line tool and integrated pixel densities were calculated by multiplying the area of each cell with the corresponding average pixel intensity after subtracting the background.
Mathematical model. All the numerical simulations were performed with Mathematica for Students (version 10.0.1.0) software package (Wolfram Research; http://www.wolfram.com). For the modelling, the experimentally determined dissociation constants of the binary complexes were used. In the case of the ternary complex, it was assumed that the binding of tubulin to the TPPP/p25-SIRT2 complex is weaker than to TPPP/p25 alone but stronger than to SIRT2 alone. The set of differential equations (see Supplementary data) were solved numerically, which allowed the determination of the time-dependent complex formation and the concentrations characteristic for the equilibrium.
Statistics. The error bars represent the standard deviation (SD). Comparisons were performed using the two-sided, unpaired Student's t-test and values were considered to be significant if the calculated p value was < 0.05 (*).
Data availability.
All data generated or analysed during this study are included in this published article (and its Supplementary Information files).
